| Old Articles: <Older 2891-2900 Newer> |
|---|
 |
Bio-IT World
May 2006
Mike May |
Drug Discovery As Easy As Pie A Johnson & Johnson pharmaceutical researcher has developed a software application that takes data from a compound, compares it to best-case values, and codes related measurements with color to assess the compound's potential as a drug.   |
Bio-IT World
May 2006
Eric Ibsen |
Collecting and Managing Animal Study Data The pivotal decision to pursue preclinical development of a drug candidate is based on animal efficacy and safety studies. Commercially available animal study management systems (ASMSs) have been recently developed and are now being successfully deployed. |
Bio-IT World
May 2006
Mark D. Uehling |
PHT, invivodata, CRF Settle Lawsuit PHT, the Boston-based electronic patient diary company, has settled two patent lawsuits. The first salvo in the legal battle was fired in January 2004, and the case was just about to go to trial when the settlement was announced early in April. |
Bio-IT World
May 2006
Salvatore Salamone |
Appliance Helps Researchers Share Large Files Researchers often use e-mail to share information and collaborate with colleagues. But attached file sizes are so large, many e-mail systems will not accept them. Now, a secure file transfer appliance from Accellion solves the problem. |
Bio-IT World
May 2006 |
News Blast Ingenious... Partners... Integration... |
Bio-IT World
May 2006
John Russell |
Metabolon's Bet on Biochemistry CEO of biopharma Metabolon is betting on metabolomics to provide a better approach to new drug discovery. |
The Motley Fool
May 11, 2006
Brian Lawler |
Encysive Evasive About Thelin The pharmaceutical stays tight-lipped about FDA approval of its new drug. Investors should keep an eye on Encysive's cash-burn rate in the coming months. |
Chemistry World
May 10, 2006
Katharine Sanderson |
Leading Lab Suppliers Merge Analytical instrument firm Thermo Electron and chemical manufacturer Fisher Scientific announced a merger, aiming to become the leading provider of laboratory products and services in the health sciences industry. |
The Motley Fool
May 10, 2006
Brian Lawler |
Dendreon Drives On Will the FDA say yes to a new cancer drug? Investors, take note. |
The Motley Fool
May 9, 2006
Brian Gorman |
No Quick Fix for Merck Two biotech purchases won't bolster the drug giant's pipeline, but they promise a longer-term payoff. Investors will have to be patient. |
| <Older 2891-2900 Newer> Return to current articles. |
